ALLERGY ANTIHISTAMINE- diphenhydramine hydrochloride tablet
EQUALINE (SuperValu)
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
----------
temporarily relieves symptoms due to hay fever or other upper respiratory allergies:
temporarily relieves these symptoms of the common cold:
a breathing problem such as emphysema or chronic bronchitis
glaucoma
trouble urinating due to an enlarged prostate gland
adults and children 12 years of age and over | take 1 to 2 tablets |
children 6 to under 12 years of age | take 1 tablet |
children under 6 years of age | do not use this product in children under 6 |
carnauba wax, colloidal silicon dioxide, croscarmellose sodium, D&C Red #27 Aluminum Lake, dibasic calcium phosphate dihydrate, hypromellose, lecithin*, magnesium stearate, microcrystalline cellulose, polyethylene glycol (PEG) 400, polysorbate 80, polyvinyl alcohol*, purified water*, talc*, titanium dioxide
*contains one or more of these ingredients
Compare to Benadryl® Allergy ultratab® Active Ingredient**
Allergy
Antihistamine
Diphenhydramine HCl 25 mg
For allergy relief:
sneezing, itchy & watery eyes, runny nose & itchy throat
**This product is not manufactured or distributed by McNeil Consumer Healthcare, Division of McNeil-PPC, Inc., owner of the registered trademark Benadryl® Allergy Ultratab®
KEEP OUTER CARTON FOR COMPLETE WARNINGS AND PRODUCT INFORMATION
DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING
DISTRIBUTED BY SUPERVALU INC.
EDEN PRAIRIE, MN 55344 USA
ALLERGY
ANTIHISTAMINE
diphenhydramine hcl tablet |
||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
|
Labeler - EQUALINE (SuperValu) (006961411) |
Registrant - P and L Development of New York Corporation (800014821) |